For the blood levels to be steady, equipoise needs to be administered at least once a week. In men, the common dosage is in the range of 400-600mg while in women it is around 50-150 mg per week. Stacking with Anadrol , Diabanol , or other injectable testosterone steroids like Sustanon or Testoviron depot can contribute to mass development. This steroid is a great hit among those who are preparing for contests as it does not aromatize well at all. Combining equipoise with Winstrol or Parabolan can greatly improve muscle hardness and density.
Equipoise is most effective when stacked with other performance enhancers. It should not be used for more than 16 weeks at a stretch. Users will notice improved blood flow and better blood volume as the cycle goes on. Effects are likely to appear a few weeks after you start the cycle.
Women bodybuilders are also fond of this steroid due to its mild nature and low androgenic properties. The most often side effect of the drug being an increase in libido, women find that the drug rarely causes any masculizing side effects when kept in a reasonable dosage range.
Male bodybuilders generally take Boldenone in doses of 300-800mg's a week for 8-20wks, depending on goals, while women bodybuilders often find a dosage of 50-100mg's a week to be very effective for making quality gains while keeping side effects to a minimum. This steroid has a long half life (7-10) days and is most commonly injected twice per week to keep blood concentrations as steady as possible.
Equipoise is available as 250-400mg/ml injectable vials and ampoules. An effective dose is 250mg per week or up to 2mg per pound of body weight. Equipoise can be used for the full length of the steroid cycle however the concentration of boldenone accumulates in the body due to its long 14-day half-life undecylenate ester. It stacks well with anavar at 20-25mg every day or dianabol at 15-20mg every day or testosterone cypionate at 250mg per week to increase muscle growth or winstrol at 50mg every other day to increase muscle hardness.